Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Lymphoma Gene Therapy
Research from Tulane University, University Health Science Center in the area of lymphoma gene therapy described
February 27th, 2007
Data detailed in "Current results and future applications of radioimmunotherapy management of non-Hodgkin's lymphoma" have been presented. "Monoclonal antibodies labeled with radionuclides have become an important therapeutic tool in the treatment of patients with non-Hodgkin's lymphomas (NHL). At the present time, their use in the US is approved for patients with rituximab-resistant, low-grade, follicular or transformed NHL," scientists in the United States report. "Encouraging responses seen in the relapsed and refractory patients have prompted their evaluation in earlier disease or in other histologic sub-types either alone or in combination with conventional...
Source: Cancer Weekly (2007-02-27)
|
